# AbbVie Inc. (ABBV) — merger/definitive [pending]
Source: SEC API (secapi.ai) · situation sit_c2734635ae54d3c8d43f · retrieved 2026-08-11T15:53:11.688Z

## Overview
AbbVie Inc. is a pharmaceutical company with a diverse portfolio spanning immunology, neuroscience, oncology, and aesthetics, including key brands such as Skyrizi, Rinvoq, Humira, Vraylar, Botox, and Venclexta.

AbbVie Inc. announced a definitive agreement to acquire Apogee Therapeutics and its pipeline of clinical-stage immunology candidates, including zumilokibart (APG777), a late-stage monoclonal antibody for atopic dermatitis, and APG273, a combination therapy for asthma. The transaction values Apogee at approximately $10.9 billion in total equity value and is expected to close in the third quarter of 2026. AbbVie updated its 2026 adjusted diluted EPS guidance to reflect a $0.14 per share dilutive impact from the proposed acquisition.

## Terms
- Counterparty: Apogee Therapeutics · Deal value: $10.90B

## Key dates
- Announced 2026-07-31 · Expected close 2026-09-30

## Timeline
- 2026-07-31 · 8-K (0001551152-26-000023): 8-K - AbbVie Inc. — *AbbVie Inc. is a pharmaceutical company with a diverse portfolio spanning immunology, neuroscience, oncology, and aesthetics, including key brands such as Skyrizi, Rinvoq, Humira, Vraylar, Botox, and Venclexta.* AbbVie Inc. announced a definitive agreement to acquire Apogee Therapeutics and its pipeline of clinical-stage immunology candidates, including zumilokibart (APG777), a late-stage monoclonal antibody for atopic dermatitis, and APG273, a combination therapy for asthma. The transaction values Apogee at approximately $10.9 billion in total equity value and is expected to close in the third quarter of 2026. AbbVie updated its 2026 adjusted diluted EPS guidance to reflect a $0.14 per share dilutive impact from the proposed acquisition.
  https://www.sec.gov/Archives/edgar/data/1551152/0001551152-26-000023.txt

## Citations
- 0001551152-26-000023 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000155115226000023